Institut de Génétique et de Biologie Moléculaire et Cellulaire, Illkirch 67404, France.
Centre National de la Recherche Scientifique, Unité Mixte de Recherche 7104, Illkirch 67404, France.
J Neurosci. 2021 Jun 2;41(22):4910-4936. doi: 10.1523/JNEUROSCI.1882-20.2021. Epub 2021 Apr 22.
Spinocerebellar ataxia type 7 (SCA7) is an inherited neurodegenerative disease mainly characterized by motor incoordination because of progressive cerebellar degeneration. SCA7 is caused by polyglutamine expansion in ATXN7, a subunit of the transcriptional coactivator SAGA, which harbors histone modification activities. Polyglutamine expansions in specific proteins are also responsible for SCA1-SCA3, SCA6, and SCA17; however, the converging and diverging pathomechanisms remain poorly understood. Using a new SCA7 knock-in mouse, SCA7, we analyzed gene expression in the cerebellum and assigned gene deregulation to specific cell types using published datasets. Gene deregulation affects all cerebellar cell types, although at variable degree, and correlates with alterations of SAGA-dependent epigenetic marks. Purkinje cells (PCs) are by far the most affected neurons and show reduced expression of 83 cell-type identity genes, including these critical for their spontaneous firing activity and synaptic functions. PC gene downregulation precedes morphologic alterations, pacemaker dysfunction, and motor incoordination. Strikingly, most PC genes downregulated in SCA7 have also decreased expression in SCA1 and SCA2 mice, revealing converging pathomechanisms and a common disease signature involving cGMP-PKG and phosphatidylinositol signaling pathways and LTD. Our study thus points out molecular targets for therapeutic development, which may prove beneficial for several SCAs. Furthermore, we show that SCA7 males and females exhibit the major disease features observed in patients, including cerebellar damage, cerebral atrophy, peripheral nerves pathology, and photoreceptor dystrophy, which account for progressive impairment of behavior, motor, and visual functions. SCA7 mice represent an accurate model for the investigation of different aspects of SCA7 pathogenesis. Spinocerebellar ataxia 7 (SCA7) is one of the several forms of inherited SCAs characterized by cerebellar degeneration because of polyglutamine expansion in specific proteins. The ATXN7 involved in SCA7 is a subunit of SAGA transcriptional coactivator complex. To understand the pathomechanisms of SCA7, we determined the cell type-specific gene deregulation in SCA7 mouse cerebellum. We found that the Purkinje cells are the most affected cerebellar cell type and show downregulation of a large subset of neuronal identity genes, critical for their spontaneous firing and synaptic functions. Strikingly, the same Purkinje cell genes are downregulated in mouse models of two other SCAs. Thus, our work reveals a disease signature shared among several SCAs and uncovers potential molecular targets for their treatment.
脊髓小脑性共济失调 7 型(SCA7)是一种主要表现为进行性小脑变性导致运动协调障碍的遗传性神经退行性疾病。SCA7 是由于转录共激活因子 SAGA 的一个亚基 ATXN7 中的多聚谷氨酰胺扩展引起的,该亚基具有组蛋白修饰活性。特定蛋白质中的多聚谷氨酰胺扩展也负责 SCA1-SCA3、SCA6 和 SCA17;然而,趋同和发散的发病机制仍知之甚少。我们使用一种新型 SCA7 基因敲入小鼠 SCA7,分析了小脑的基因表达,并使用已发表的数据集将基因失调分配给特定的细胞类型。基因失调影响所有的小脑细胞类型,尽管程度不同,但与 SAGA 依赖性表观遗传标记的改变相关。浦肯野细胞(PCs)是迄今为止受影响最大的神经元,其 83 种细胞类型特征基因的表达减少,包括对其自发放电活动和突触功能至关重要的基因。PC 基因下调发生在形态改变、起搏功能障碍和运动协调障碍之前。引人注目的是,在 SCA7 中下调的大多数 PC 基因在 SCA1 和 SCA2 小鼠中也有表达降低,这表明存在趋同的发病机制和共同的疾病特征,涉及 cGMP-PKG 和磷脂酰肌醇信号通路和 LTD。因此,我们的研究指出了治疗开发的分子靶点,这可能对几种 SCA 有益。此外,我们发现 SCA7 雄性和雌性表现出患者中观察到的主要疾病特征,包括小脑损伤、大脑萎缩、周围神经病理学和光感受器变性,这导致行为、运动和视觉功能的进行性损伤。SCA7 小鼠代表了研究 SCA7 发病机制不同方面的准确模型。脊髓小脑性共济失调 7 型(SCA7)是几种遗传性 SCA 中的一种,其特征是由于特定蛋白质中的多聚谷氨酰胺扩展导致小脑变性。涉及 SCA7 的 ATXN7 是 SAGA 转录共激活因子复合物的一个亚基。为了了解 SCA7 的发病机制,我们确定了 SCA7 小鼠小脑的特定细胞类型的基因失调。我们发现浦肯野细胞是受影响最大的小脑细胞类型,其神经元特征基因的大部分子集下调,这些基因对其自发放电和突触功能至关重要。引人注目的是,两种其他 SCA 的小鼠模型中也下调了相同的浦肯野细胞基因。因此,我们的工作揭示了几种 SCA 之间共享的疾病特征,并揭示了其治疗的潜在分子靶点。